APA (7th ed.) Citation

Streciwilk, W., Terenzi, A., Cheng, X., Hager, L., Dabiri, Y., Prochnow, P., . . . Ott, I. (2018). Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interaction. European journal of medicinal chemistry, 156, . https://doi.org/10.1016/j.ejmech.2018.06.056

Chicago Style (17th ed.) Citation

Streciwilk, Wojciech, et al. "Fluorescent Organometallic Rhodium(I) and Ruthenium(II) Metallodrugs with 4-ethylthio-1,8-naphthalimide Ligands: Antiproliferative Effects, Cellular Uptake and DNA-interaction." European Journal of Medicinal Chemistry 156 (2018). https://doi.org/10.1016/j.ejmech.2018.06.056.

MLA (9th ed.) Citation

Streciwilk, Wojciech, et al. "Fluorescent Organometallic Rhodium(I) and Ruthenium(II) Metallodrugs with 4-ethylthio-1,8-naphthalimide Ligands: Antiproliferative Effects, Cellular Uptake and DNA-interaction." European Journal of Medicinal Chemistry, vol. 156, 2018, https://doi.org/10.1016/j.ejmech.2018.06.056.